Treatment in Children

  • Corina Isabel Salas-Callo
  • Rodrigo Pirmez


Hair loss in children causes great emotional impact in both patients and relatives. Particularities of this age group along with the lack of clinical trials make therapy in children many times challenging for physicians. In this chapter, we discuss treatments of common types of hair loss in children such as tinea capitis, alopecia areata, trichotillomania, hair shaft disorders, and others based on current literature and experience.


Children Hair loss Alopecia Alopecia areata Trichotillomania Tinea capitis Aplasia cutis Trichorrhexis nodosa Netherton Pili torti Monilethrix Trichorrhexis invaginata Trichothiodystrophy Uncombable hair Woolly hair Griseofulvin Terbinafine Itraconazole Fluconazole Steroids Minoxidil 


  1. 1.
    Castelo-Soccio L. Diagnosis and management of alopecia in children. Pediatr Clin N Am. 2014;61:427–42.Google Scholar
  2. 2.
    Elghblawi E. Tinea capitis in children and trichoscopic criteria. Int J Trichol. 2017;9(2):47–9.Google Scholar
  3. 3.
    Gupta AK, Mays RR, Versteeg SG, Piraccini BM, Shear NH, Piguet V, et al. Tinea capitis in children: a systematic review of management. J Eur Acad Dermatol Venereol. 2018;32(12):2264–74.PubMedGoogle Scholar
  4. 4.
    Chen X, Jiang X, Yang M, Bennett C, González U, Lin X, et al. Systemic antifungal therapy for tinea capitis in children: an abridged cochrane review. J Am Acad Dermatol. 2017;76(2):368–74.PubMedGoogle Scholar
  5. 5.
    Bijanzadeh M, Mahmoudian M, Salehian P, Khazainia T, Eshghi L, Khosravy A. The bioavailability of griseofulvin from microsized and ultramicrosized tablets in nonfasting volunteers. Indian J Physiol Pharmacol. 1990;34(3):157–61.PubMedGoogle Scholar
  6. 6.
    Fuller LC, Barton RC, Mohd Mustapa MF, Proudfoot LE, Punjabi SP, Higgins EM. British Association of Dermatologists’ guidelines for the management of tinea capitis 2014. Br J Dermatol. 2014;171(3):454–63.PubMedGoogle Scholar
  7. 7.
    Gupta AK. Systemic antifungal agents. In: Wolverton SE, editor. Comprehensive dermatologic drug therapy. 3rd ed. Philadelphia: Elsevier; 2013. p. 98–120.Google Scholar
  8. 8.
    Chen S, Sun KY, Feng XW, Ran X, Lama J, Ran YP. Efficacy and safety of itraconazole use in infants. World J Pediatr. 2016;12(4):399–407.PubMedGoogle Scholar
  9. 9.
    Koumantaki-Mathioudaki E, Devliotou-Panagiotidou D, Rallis E, Athanassopoulou V, Koussidou-Eremondi T, Katsambas A, et al. Is itraconazole the treatment of choice in Microsporum canis tinea capitis? Drugs Exp Clin Res. 2005;31 Suppl:11–5.PubMedGoogle Scholar
  10. 10.
    Binder B, Richtig E, Weger W, Ginter-Hanselmayer G. Tinea capitis in early infancy treated with itraconazole: a pilot study. J Eur Acad Dermatol Venereol. 2009;23:1161–3.PubMedGoogle Scholar
  11. 11.
    Foster KW, Friedlander SF, Panzer H, Ghannoum MA, Elewski BE. A randomized controlled trial assessing the efficacy of fluconazole in the treatment of pediatric tinea capitis. J Am Acad Dermatol. 2005;53(5):798–809.PubMedGoogle Scholar
  12. 12.
    Peloquin L, Castelo-Soccio L. Alopecia areata: an update on treatment options for children. Pediatr Drugs. 2017;19:411–22.Google Scholar
  13. 13.
    Alkhalifah A, Alsantali A, Wang E, Kevin J, McElwee KJ, Shapiro J. Alopecia areata update. Part I. Clinical picture, histopathology, and pathogenesis. J Am Acad Dermatol. 2010;62(2):191–202.PubMedGoogle Scholar
  14. 14.
    Waśkiel A, Rakowska A, Sikora M, Olszewska M, Rudnicka L. Trichoscopy of alopecia areata: an update. J Dermatol. 2018;45(6):692–700.Google Scholar
  15. 15.
    Lenane P, Macarthur C, Parkin PC, Krafchik B, DeGroot J, Khambalia A, et al. Clobetasol propionate, 0.05%, vs hydrocortisone, 1%, for alopecia areata in children. A Randomized Clinical Trial. JAMA Dermatol. 2014;150(1):47–50.PubMedGoogle Scholar
  16. 16.
    Iorizzo M, Oranje AP. Current and future treatments of alopecia areata and trichotillomania in children. Expert Opin Pharmacother. 2016;17(13):1767–73.PubMedGoogle Scholar
  17. 17.
    Salsberg JM, Jeff Donovan J. The safety and efficacy of diphencyprone for the treatment of alopecia areata in children. Arch Dermatol. 2012;148(9):1084–5.PubMedGoogle Scholar
  18. 18.
    Alkhalifah A, Alsantali A, Wang E, McElwee KJ, Shapiro J. Alopecia areata update: part II. Treatment. J Am Acad Dermatol. 2010;62(2):191–202.PubMedGoogle Scholar
  19. 19.
    Wu SZ, Wang S, Ratnaparkhi R, Bergfeld WF. Treatment of pediatric alopecia areata with anthralin: a retrospective study of 37 patients. Pediatr Dermatol. 2018;35(6):817–20.PubMedGoogle Scholar
  20. 20.
    Özdemir M, Balevi A. Bilateral half-head comparison of 1% anthralin ointment in children with alopecia areata. Pediatr Dermatol. 2017;34(2):128–32.PubMedGoogle Scholar
  21. 21.
    Daunton A, Harries M. Efficacy of topical dithranol (Dithrocream®) in the treatment of alopecia areata: a retrospective case series. Br J Dermatol. 2019;180(5):1246–7.PubMedGoogle Scholar
  22. 22.
    Durdu M, Özcan D, Baba M, Seçkin D. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series. J Am Acad Dermatol. 2015;72(4):640–50.PubMedGoogle Scholar
  23. 23.
    Strazzulla LC, Wang EHC, Avila L, Lo Sicco K, Brinster N, Christiano AM, et al. Alopecia areata: an appraisal of new treatment approaches and overview of current therapies. J Am Acad Dermatol. 2018;78(1):15–24.PubMedGoogle Scholar
  24. 24.
    Bayart CB, DeNiro KL, Brichta L, Craiglow BG, Sidbury R. Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata. J Am Acad Dermatol. 2017;77(1):167–70.Google Scholar
  25. 25.
    Craiglow BG, Tavares D, King BA. Topical ruxolitinib for the treatment of alopecia Universalis. JAMA Dermatol. 2016;152(4):490–1.PubMedGoogle Scholar
  26. 26.
    Georgala S, Befon A, Maniatopoulou E, Georgala C. Topical use of minoxidil in children and systemic side effects. Dermatology. 2007;214(1):101–2.PubMedGoogle Scholar
  27. 27.
    Talpur R, Vu J, Bassett R, Stevens V, Duvic M. Phase I/II randomized bilateral half-head comparison of topical bexarotene 1% gel for alopecia areata. J Am Acad Dermatol. 2009;61(4):592.e1–9.Google Scholar
  28. 28.
    Zaher H, Gawdat HI, Hegazy RA, et al. Bimatoprost versus mometasone furoate in the treatment of scalp alopecia areata: a pilot study. Dermatology. 2015;230:308–13.PubMedGoogle Scholar
  29. 29.
    Li AW, Antaya RJ. Successful treatment of pediatric alopecia areata of the scalp using topical bimatoprost. Pediatr Dermatol. 2016;33(5):e282–3.PubMedGoogle Scholar
  30. 30.
    Chu TW, AlJasser M, Alharbi A, Abahussein O, McElwee K, Shapiro J. Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: an intrasubject pilot study. J Am Acad Dermatol. 2015;73:338–40.PubMedGoogle Scholar
  31. 31.
    Sharma VK, Muralidhar S. Treatment of widespread alopecia areata in young patients with monthly oral corticosteroid pulse. Pediatr Dermatol. 1998;15(4):313–7.PubMedGoogle Scholar
  32. 32.
    Friedland R, Tal R, Lapidoth M, Zvulunov A, Ben Amitai D. Pulse corticosteroid therapy for alopecia areata in children: a retrospective study. Dermatology. 2013;227(1):37–44.PubMedGoogle Scholar
  33. 33.
    Lalosevic J, Gajic-Veljic M, Bonaci-Nikolic B, Nikolic M. Combined oral pulse and topical corticosteroid therapy for severe alopecia areata in children: a long-term follow-up study. Dermatol Ther. 2015;28(5):309–17.PubMedGoogle Scholar
  34. 34.
    Shreberk-Hassidim R, Ramot Y, Gilula Z, Zlotogorski A. A systematic review of pulse steroid therapy for alopecia areata. J Am Acad Dermatol. 2016;74(2):372–4.e1–5.PubMedGoogle Scholar
  35. 35.
    Royer M, Bodemer C, Vabres P, Pajot C, Barbarot S, Paul C, et al. Efficacy and tolerability of methotrexate in severe childhood alopecia areata. Br J Dermatol. 2011;165(2):407–10.PubMedGoogle Scholar
  36. 36.
    Chandran NS, Novak J, Iorizzo M, Grimalt R, Oranje AP. Trichotillomania in children. Skin Appendage Disord. 2015;1(1):18–24.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Alves R, Grimalt R. Hair loss in children. Curr Probl Dermatol. 2015;47:55–66.PubMedGoogle Scholar
  38. 38.
    Rakowska A, Slowinska M, Olszewska M, Rudnicka L. New trichoscopy findings in trichotillomania: flame hairs, V-sign, hook hairs, hair powder, tulip hairs. Acta Derm Venereol. 2014;94(3):303–6.PubMedGoogle Scholar
  39. 39.
    De Sousa A. An open-label pilot study of naltrexone in childhood-onset trichotillomania. J Child Adolesc Psychopharmacol. 2008;18(1):30–3.PubMedGoogle Scholar
  40. 40.
    Grant JE, Odlaug BL, Kim SW. N-acetylcysteine, a glutamate modulator in the treatment of trichotillomania. A double-blind, placebo-controlled study. Arch Gen Psychiatry. 2009;66(7):756–63.PubMedGoogle Scholar
  41. 41.
    Bloch MH, Panza KE, Grant JE, Pittenger C, Leckman JF. N-acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-ontrial. J Am Acad Child Adolesc Psychiatry. 2013;52(3)Google Scholar
  42. 42.
    Yamazaki M, Irisawa R, Tsuboi R. Temporal triangular alopecia and a review of 52 past cases. J Dermatol. 2010;37:360–2.PubMedGoogle Scholar
  43. 43.
    Trakimas CA, Sperling LC. Temporal triangular alopecia acquired in adulthood. J Am Acad Dermatol. 1999;40(5 Pt 2):842–4.PubMedGoogle Scholar
  44. 44.
    Yin Li VC, Yesudian PD. Congenital triangular alopecia. Int J Trichol. 2015;7(2):48–53.Google Scholar
  45. 45.
    Fernández-Crehuet P, Vaño-Galván S, Martorell-Calatayud A, Arias-Santiago S, Grimalt R, Camacho-Martínez FM. Clinical and trichoscopic characteristics of temporal triangular alopecia: a multicenter study. J Am Acad Dermatol. 2016;75(3):634–7.PubMedGoogle Scholar
  46. 46.
    Bang CY, Byun JW, Kang MJ, Yang BH, Song HJ, Shin J, et al. Successful treatment of temporal triangular alopecia with topical minoxidil. Ann Dermatol. 2013;25:387–8.PubMedPubMedCentralGoogle Scholar
  47. 47.
    Wu WY, Otberg N, Kang H, Zanet L, Shapiro J. Successful treatment of temporal triangular alopecia by hair restoration surgery using follicular unit transplantation. Dermatol Surg. 2009;35(8):1307–10.PubMedGoogle Scholar
  48. 48.
    AlShehri W, AlFadil S, AlOthri A, Alabdulkarim AO, Wani SA, Rabah SM. Aplasia cutis congenita of the scalp with a familial pattern: a case report. World J Plast Surg. 2016;5(3):298–302.PubMedPubMedCentralGoogle Scholar
  49. 49.
    Kruk-Jeromin J, Janik J, Rykała J. Aplasia cutis congenita of the scalp. Report of 16 cases. Dermatol Surg. 1998;24(5):549–53.PubMedGoogle Scholar
  50. 50.
    Rakowska A, Maj M, Zadurska M, Czuwara J, Warszawik-Henzel O, Olszewska M, et al. Trichoscopy of focal alopecia in children - new trichoscopic findings: hair bulbs arranged radially along hair-bearing margins in aplasia cutis congenita. Skin Appendage Disord. 2016;2(1–2):1–6.PubMedPubMedCentralGoogle Scholar
  51. 51.
    Tosti A. Pediatric hair disorders. In: Tosti A, editor. Dermoscopy of the hair and nails. 2nd ed. Boca Raton, FL: CRC Press; 2016. p. 79–85.Google Scholar
  52. 52.
    Frieden IJ. Aplasia cutis congenita: a clinical review and proposal for classification. J Am Acad Dermatol. 1986;14(4):646–60.PubMedGoogle Scholar
  53. 53.
    Belkhou A, François C, Bennis Y, Duquennoy-Martinot V, Guerreschi P. Aplasia cutis congenita: update and management. Ann Chir Plast Esthet. 2016;61(5):450–61.PubMedGoogle Scholar
  54. 54.
    Miteva M, Tosti A. Dermatoscopy of hair shaft disorders. J Am Acad Dermatol. 2013;68:473–81.PubMedGoogle Scholar
  55. 55.
    Singh G, Miteva M. Prognosis and management of congenital hair shaft disorders with fragility-part I. Pediatr Dermatol. 2016;33(5):473–80.PubMedGoogle Scholar
  56. 56.
    Rudnicka L, Olszewska M, Waśkiel A, Rakowska A. Trichoscopy in hair shaft disorders. Dermatol Clin. 2018;36:421–30.PubMedGoogle Scholar
  57. 57.
    Rakowska A, Slowinska M, Kowalska-Oledzka E, Rudnicka L. Trichoscopy in genetic hair shaft abnormalities. J Dermatol Case Rep. 2008;2:14–20.PubMedPubMedCentralGoogle Scholar
  58. 58.
    Mirmirani P, Huang KP, Price VH. A practical, algorithmic approach to diagnosing hair shaft disorders. Int J Dermatol. 2011;50(1):1–12.PubMedGoogle Scholar
  59. 59.
    Singh G, Miteva M. Prognosis and management of congenital hair shaft disorders without fragility-part II. Pediatr Dermatol. 2016;33(5):481–7.PubMedGoogle Scholar
  60. 60.
    Cheng AS, Bayliss SJ. The genetics of hair shaft disorders. J Am Acad Dermatol. 2008;59(1):1–22.PubMedGoogle Scholar
  61. 61.
    Karincaoglu Y, Coskun BK, Seyhan ME, Bayram N. Monilethrix: improvement with acitretin. Am J Clin Dermatol. 2005;6(6):407–10.PubMedGoogle Scholar
  62. 62.
    De Berker D, Dawber RP. Monilethrix treated with oral retinoids. Clin Exp Dermatol. 1991;16(3):226–8.PubMedGoogle Scholar
  63. 63.
    Rossi A, Iorio A, Scali E, Fortuna MC, Mari E, Palese E, et al. Monilethrix treated with minoxidil. Int J Immunopathol Pharmacol. 2011;24(1):239–42.PubMedGoogle Scholar
  64. 64.
    Sun JD, Linden KG. Netherton syndrome: a case report and review of the literature. Int J Dermatol. 2006;45(6):693–7.PubMedGoogle Scholar
  65. 65.
    Itin PH, Sarasin A, Pittelkow MR. Trichothiodystrophy: update on the sulfur-deficient brittle hair syndromes. J Am Acad Dermatol. 2001;44(6):891–920; quiz 921–4.PubMedGoogle Scholar
  66. 66.
    Faghri S, Tamura D, Kraemer KH, Digiovanna JJ. Trichothiodystrophy: a systematic review of 112 published cases characterises a wide spectrum of clinical manifestations. J Med Genet. 2008;45(10):609–21.PubMedPubMedCentralGoogle Scholar
  67. 67.
    Richards KA, Mancini AJ. Three members of a family with pili torti and sensorineural hearing loss: the Bjornstad syndrome. J Am Acad Dermatol. 2002;46(2):301–3.PubMedGoogle Scholar
  68. 68.
    Telfer NR, Cutler TP, Dawber RP. The natural history of ‘dystrophic’ pili torti. Br J Dermatol. 1989;120(2):323–5.PubMedGoogle Scholar
  69. 69.
    Ferrando J, Grimalt R. Pediatric hair disorders: an atlas and text. 3rd ed. Boca Raton, FL: CRC Press; 2017. p. 1–35.Google Scholar
  70. 70.
    Albers LN, Maley AM, MacKelfresh JB. Blowing bubbles: dermoscopy of bubble hair. Int J Trichol. 2017;9(3):122–3.Google Scholar
  71. 71.
    Castelli E, Fiorella S, Caputo V. Pili annulati coincident with alopecia areata, autoimmune thyroid disease, and primary IgA deficiency: case report and considerations on the literature. Case Rep Dermatol. 2012;4:250–5.PubMedPubMedCentralGoogle Scholar
  72. 72.
    Hicks J, Metry DW, Barrish J, Levy M. Uncombable hair (cheveux incoiffables, pili trianguli et canaliculi) syndrome: brief review and role of scanning electron microscopy in diagnosis. Ultrastruct Pathol. 2001;25(2):99–103.PubMedGoogle Scholar
  73. 73.
    Calderon P, Otberg N, Shapiro J. Uncombable hair syndrome. J Am Acad Dermatol. 2009;61(3):512–5.PubMedGoogle Scholar
  74. 74.
    Cho S, Choi MJ, Zheng Z, Goo B, Kim DY, Cho SB. Clinical effects of non-ablative and ablative fractional lasers on various hair disorders: a case series of 17 patients. J Cosmet Laser Ther. 2013;15(2):74–9.PubMedGoogle Scholar
  75. 75.
    Cantatore-Francis JL, Orlow SJ. Practical guidelines for evaluation of loose anagen hair syndrome. Arch Dermatol. 2009;145(10):1123–8.PubMedGoogle Scholar
  76. 76.
    Mirmirani P, Uno H, Price VH. Abnormal inner root sheath of the hair follicle in the loose anagen hair syndrome: an ultrastructural study. J Am Acad Dermatol. 2011;64(1):129–34.PubMedGoogle Scholar
  77. 77.
    Tosti A, Piraccini BM. Loose anagen hair syndrome and loose anagen hair. Arch Dermatol. 2002;138(4):521–2.Google Scholar
  78. 78.
    Oberlin KE, Maddy AJ, MartınezVelasco MA, Vazquez-Herrera NE, Schachner LA, Tosti A. Short anagen syndrome: case series and literature review. Pediatr Dermatol. 2018;00:1–4.Google Scholar
  79. 79.
    Herskovitz I, de Sousa IC, Simon J, Tosti A. Short anagen hair syndrome. Int J Trichol. 2013;5(1):45–6.Google Scholar
  80. 80.
    Giacomini F, Starace M, Tosti A. Short anagen syndrome. Pediatr Dermatol. 2011;28(2):133–4.PubMedGoogle Scholar
  81. 81.
    Cheng YP, Chen YS, Lin SJ, Hsiao CH, Chiu HC, Chan JL. Minoxidil improved hair density in an Asian girl with short anagen syndrome: a case report and review of literature. Int J Dermatol. 2016;55(11):1268–71.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Corina Isabel Salas-Callo
    • 1
  • Rodrigo Pirmez
    • 2
  1. 1.Instituto de Dermatologia Professor Rubem David Azulay, Santa Casa da Misericórdia do Rio de Janeiro, Department of DermatologyRio de JaneiroBrazil
  2. 2.Department of Dermatology Santa Casa da MisericordiaRio De JaneiroBrazil

Personalised recommendations